Related references
Note: Only part of the references are listed.The role of endothelial-to-mesenchymal transition in cancer progression
S. Potenta et al.
BRITISH JOURNAL OF CANCER (2008)
Rac1 activation controls nuclear localization of β-catenin during canonical Wnt signaling
Ximei Wu et al.
CELL (2008)
KEGG for linking genomes to life and the environment
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2008)
Onto-Tools: new additions and improvements in 2006
Purvesh Khatri et al.
NUCLEIC ACIDS RESEARCH (2007)
Phosphodiesterase 1 upregulation in pulmonary arterial hypertension target for reverse-remodeling therapy
Ralph Theo Schermuly et al.
CIRCULATION (2007)
Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange
Norbert Weissmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The role of K+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis:: Implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension
Rohit Moudgil et al.
MICROCIRCULATION (2006)
Mobility and invasiveness of metastatic esophageal cancer are potentiated by shear stress in a ROCK- and Ras-dependent manner
Karen Lawler et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS
Pascal Guerard et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2006)
Long term imatinib treatment in pulmonary arterial hypertension
R. Souza et al.
THORAX (2006)
The multiple languages of endothelial cell-to-cell communication
Stefan Liebner et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Laser-microdissection for cell type- and compartment-specific analyses on genomic and proteomic level
Ludger Fink et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2006)
Beneficial acute effects of Rho-kinase inhibitor in patients with pulmonary arterial hypertension
K Ishikura et al.
CIRCULATION JOURNAL (2006)
Wnt signalling in lung development and diseases
JE Pongracz et al.
RESPIRATORY RESEARCH (2006)
Upregulated genes in sporadic, idiopathic pulmonary arterial hypertension -: art. no. 1
AJ Edgar et al.
RESPIRATORY RESEARCH (2006)
From genomics to chemical genomics: new developments in KEGG
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2006)
Mts1/S100A4 stimulates human pulmonary artery smooth muscle cell migration through multiple signaling pathways
E Spiekerkoetter et al.
CHEST (2005)
Hypoxia down-regulates cyclic guanidine monophosphate-dependent protein kinase in fetal pulmonary vascular smooth muscle cell through generation of reactive oxygen species and promotes development of pulmonary hypertension
F Sander et al.
CHEST (2005)
Sildenafil citrate therapy for pulmonary arterial hypertension
N Galiè et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Reversal of experimental pulmonary hypertension by PDGF inhibition
RT Schermuly et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Divergent effects of BMP-2 on gene expression in pulmonary artery smooth muscle cells from normal subjects and patients with idiopathic pulmonary arterial hypertension
I Fantozzi et al.
EXPERIMENTAL LUNG RESEARCH (2005)
Imatinib for the treatment of pulmonary arterial hypertension
HA Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Expression profiling of laser-microdissected intrapulmonary arteries in hypoxia-induced pulmonary hypertension
G Kwapiszewska et al.
RESPIRATORY RESEARCH (2005)
Increased fibulin-5 and elastin in S100A4/Mts1 mice with pulmonary hypertension
SL Merklinger et al.
CIRCULATION RESEARCH (2005)
Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension
SL Merklinger et al.
CIRCULATION (2005)
Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension
MS McMurtry et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Prognostically useful gene-expression profiles in acute myeloid leukemia
PJM Valk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia
L Bullinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats
K Abe et al.
CIRCULATION RESEARCH (2004)
limmaGUI: A graphical user interface for linear modeling of microarray data
JM Wettenhall et al.
BIOINFORMATICS (2004)
Identification of proteins in laser-microdissected small cell numbers by SELDI-TOF and Tandem MS
G Kwapiszewska et al.
BMC BIOTECHNOLOGY (2004)
Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats
RT Schermuly et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Wnt11 signaling promotes proliferation, transformation, and migration of IEC6 intestinal epithelial cells
L Ouko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension
TM Bull et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Prostacyclin and its analogues in the treatment of pulmonary hypertension
H Olschewski et al.
PHARMACOLOGY & THERAPEUTICS (2004)
β-catenin is required for specification of proximal/distal cell fate during lung morphogenesis
ML Mucenski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Aberrant Wnt/β-catenin pathway activation in idiopathic pulmonary fibrosis
M Chilosi et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Biological properties and gene expression associated with metastatic potential of human osteosarcoma
T Nakano et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
Proliferation, but not apoptosis, is associated with distinct β-catenin expression patterns in non-small-cell lung carcinomas -: Relationship with adenomatous polyposis coli and G1- to S-phase cell-cycle regulators
A Kotsinas et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Amplification of the pulmonary vasodilatory response to inhaled iloprost by subthreshold phosphodiesterase types 3 and 4 inhibition in severe pulmonary hypertension
HA Ghofrani et al.
CRITICAL CARE MEDICINE (2002)
The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis?
N Hopkins et al.
JOURNAL OF ANATOMY (2002)
Wnt5a participates in distal lung morphogenesis
CG Li et al.
DEVELOPMENTAL BIOLOGY (2002)
Bosentan therapy for pulmonary arterial hypertension
LJ Rubin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
cDNA array hybridization after laser-assisted microdissection from nonneoplastic tissue
L Fink et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Direct evidence for a. role of beta-catenin/LEF-1 signaling pathway in induction of EMT
K Kim et al.
CELL BIOLOGY INTERNATIONAL (2002)
Endogenously released endothelin-1 from human pulmonary artery smooth muscle promotes cellular proliferation - Relevance to pathogenesis of pulmonary hypertension and vascular remodeling
SJ Wort et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2001)
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
J Khan et al.
NATURE MEDICINE (2001)
Gene expression patterns in the lungs of patients with primary pulmonary hypertension - A gene microarray analysis
MW Geraci et al.
CIRCULATION RESEARCH (2001)
Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene
ZM Deng et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension
KB Lane et al.
NATURE GENETICS (2000)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
